Table I.
Time (h) | Treatment | PSGL-1 levels | ||
---|---|---|---|---|
Unstimulated | IL-1β 10 ng/mL | IL-1β 100 ng/mL | ||
0 | 93.9 ± 4.9 | – | – | % |
35 ± 7.9 | – | – | MFI | |
24 | 75.5 ± 15.5 | 83.1 ± 6.6 | 83.7 ± 5.9 | % |
11.6 ± 3.8 | 17.0 ± 5.3 | 17.5 ± 7.6 | MFI | |
48 | 71.8 ± 0.5 | 82.9 ± 0.5 | 84.5 ± 5.5 | % |
14.1 ± 4.1 | 30.9 ± 1.1 | 38.3 ± 10.9 | MFI |